Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 24 studies | 45% ± 24% | |
connective tissue cell | 14 studies | 41% ± 24% | |
mesothelial cell | 11 studies | 46% ± 19% | |
myofibroblast cell | 4 studies | 66% ± 9% | |
adventitial cell | 4 studies | 44% ± 9% | |
pericyte | 4 studies | 24% ± 7% | |
smooth muscle cell | 3 studies | 42% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 28% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 84% | 3614.62 | 206 / 245 | 94% | 24.52 | 470 / 502 |
breast | 86% | 5171.92 | 397 / 459 | 71% | 23.90 | 795 / 1118 |
ovary | 99% | 7916.22 | 178 / 180 | 39% | 7.85 | 166 / 430 |
uterus | 98% | 7216.01 | 166 / 170 | 25% | 30.36 | 116 / 459 |
esophagus | 65% | 2643.04 | 944 / 1445 | 36% | 6.87 | 66 / 183 |
blood vessel | 99% | 29799.32 | 1326 / 1335 | 0% | 0 | 0 / 0 |
lung | 63% | 2072.85 | 366 / 578 | 35% | 9.43 | 400 / 1155 |
intestine | 74% | 3772.21 | 718 / 966 | 23% | 5.18 | 123 / 527 |
thymus | 60% | 1866.19 | 389 / 653 | 32% | 3.85 | 193 / 605 |
stomach | 45% | 2283.37 | 162 / 359 | 42% | 17.69 | 120 / 286 |
bladder | 62% | 2194.62 | 13 / 21 | 21% | 2.83 | 104 / 504 |
pancreas | 3% | 41.52 | 9 / 328 | 67% | 16.72 | 119 / 178 |
adipose | 69% | 6580.01 | 830 / 1204 | 0% | 0 | 0 / 0 |
heart | 67% | 4021.87 | 578 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 40% | 865.36 | 104 / 258 | 22% | 2.59 | 50 / 230 |
kidney | 7% | 148.11 | 6 / 89 | 19% | 2.87 | 171 / 901 |
brain | 2% | 78.05 | 55 / 2642 | 20% | 3.65 | 143 / 705 |
skin | 7% | 113.01 | 120 / 1809 | 14% | 3.05 | 68 / 472 |
liver | 1% | 15.87 | 2 / 226 | 17% | 1.58 | 70 / 406 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.38 | 4 / 45 |
eye | 0% | 0 | 0 / 0 | 4% | 0.17 | 3 / 80 |
muscle | 1% | 17.98 | 10 / 803 | 0% | 0 | 0 / 0 |
spleen | 1% | 14.63 | 3 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 8.28 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0060348 | Biological process | bone development |
GO_0048662 | Biological process | negative regulation of smooth muscle cell proliferation |
GO_0061975 | Biological process | articular cartilage development |
GO_0005615 | Cellular component | extracellular space |
GO_0005796 | Cellular component | Golgi lumen |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031012 | Cellular component | extracellular matrix |
GO_0030021 | Molecular function | extracellular matrix structural constituent conferring compression resistance |
GO_0005515 | Molecular function | protein binding |
GO_0008083 | Molecular function | growth factor activity |
Gene name | OGN |
Protein name | Mimecan (Osteoglycin) (Osteoinductive factor) (OIF) Osteoglycin Mimecan (Osteoglycin) |
Synonyms | hCG_31130 SLRR3A OIF |
Description | FUNCTION: Induces bone formation in conjunction with TGF-beta-1 or TGF-beta-2. . FUNCTION: Induces bone formation in conjunction with TGF-beta-1 or TGF-beta-2. . |
Accessions | ENST00000707238.1 ENST00000707237.1 P20774 Q5TBF5 ENST00000262551.8 ENST00000375561.10 A8K0R3 ENST00000447356.1 |